Evidence map›Paper›PMID 38635125›Full record

ArticleInternational urology and nephrology2024

Finerenone in type 2 diabetic and albuminuric renal disease patients: three case reports.

Luca Di Lullo, Davide Salera, Cristina Galderisi, Antonio Bellasi

Erratum issuedAbstract readCase ReportsLetter
PubMed Publisher
In one paragraph

Article in International urology and nephrology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Luca Di LulloDepartment of Nephrology and Dialysis, Azienda USL Roma 6, Albano Laziale, Italy.
Davide SaleraInternal Medicine Department, Ospedale Regionale Di Lugano, Ospdeale Civico, Ente Ospedaliero Cantonale, Via Tesserete 46, 6903, Lugano, Switzerland.
Cristina GalderisiDepartment of Nephrology and Dialysis, Azienda USL Roma 6, Albano Laziale, Italy.
Antonio BellasiService of Nephrology, Ospedale Regionale Di Lugano, Ospdeale Civico, Ente Ospedaliero Cantonale, Via Tesserete 46, 6903, Lugano, Switzerland. antonio.bellasi@eoc.ch.
Azienda Sanitaria Locale Roma 3 · ITEnte Ospedaliero Cantonale · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AlbuminuriaDiabetes Mellitus, Type 2Diabetic NephropathiesMineralocorticoid Receptor AntagonistsSodium-Glucose Transporter 2 InhibitorsAgedDrug Therapy, CombinationFemaleHumansMaleMiddle AgedNaphthyridinesfinerenoneMineralocorticoid Receptor AntagonistsNaphthyridinesSodium-Glucose Transporter 2 Inhibitors

Identifiers

PMID38635125
OpenAlexW4394920626

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.